Previous Close | 0.0750 |
Open | 0.0750 |
Bid | 0.0700 x N/A |
Ask | 0.0750 x N/A |
Day's Range | 0.0700 - 0.0750 |
52 Week Range | 0.0700 - 0.3500 |
Volume | |
Avg. Volume | 153,883 |
Market Cap | 9.678M |
Beta (5Y Monthly) | 0.11 |
PE Ratio (TTM) | 2.33 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), – Canadabis Capital, and its shareholdings in Stigma Grow a leading innovator in the Canadian cannabis industry, is thrilled to announce the launch of the latest addition to the Dab Bods brand lineup – a ground breaking 60%+ double-infused pre-roll. This new offering sets a new benchmark for THC potency in the Canadian market, catering to cannabis enthusiasts seeking a premium, high-potency experience.
CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is pleased to announce results from our second quarter fiscal 2024, represented by our tenth consecutive quarter generating net revenue. The Company's Financial Statements and Notes, as well as Management's Discussion and Analysis ("MD&A") are filed on SEDAR at www.sedarplus.ca.
At the request of CIRO, CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity.